De-implementing PreOp Urine Testing
De-implementation of Unnecessary Pre-Operative Urine Testing
2 other identifiers
interventional
6
1 country
1
Brief Summary
This is a randomized study to evaluate the effectiveness and implementation of an intervention to decrease unnecessary urine testing for surgical patients (Less is More for Surgical Urine Testing) across six geographically diverse Veterans Affairs Medical Centers. The intervention will unfold over two years, in three phases: control, intervention, and sustainability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedStudy Start
First participant enrolled
December 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
Study Completion
Last participant's last visit for all outcomes
December 31, 2030
February 13, 2026
February 1, 2026
2 years
February 3, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Urine Testing Performed
Throughout the study period, the research team will generate monthly lists of all urinalyses and urine cultures performed within 30 days before and 30 days after included procedures. The study team will chart review theses cases and determine whether the urine test was done on an asymptomatic patient or whether the test was justified based on UTI symptoms.
up to 48 months
Secondary Outcomes (2)
Number of Days of Therapy
up to 48 months
Budget Impact Analysis
up to 48 months
Study Arms (2)
Intervention Site Visit
EXPERIMENTALVAMCs randomized in this arm will receive full access to our resources library, will receive invites to our monthly meetings, receive monthly feedback on clinical outcomes, access to project materials, etc.
Standard of Care
NO INTERVENTIONVAMCs randomized to the standard arm will proceed with normal standard of care
Interventions
Activities occurring during the 12-month intervention phase * 1:1 meetings introducing the project * Site Visit (once during intervention period) * Interactive teaching cases and didactic sessions * Distribution of algorithm as pocket cards * Access to project materials on SharePoint * Feedback reports on clinical outcomes * Evidence-based order set templates * Learning collaborative webinars * Individualized coaching
Eligibility Criteria
You may qualify if:
- Medical Centers part of the Veterans Affairs Health Administration (VAMCs)
- VAMCs that perform standard, intermediate, or advanced surgical procedures
- VAMCs in which perioperative urine testing is performed among greater than 10% of their non-urologic, non-transplant surgery procedures
You may not qualify if:
- VAMCs that only perform ambulatory surgery (outpatient/day surgery only)
- VAMCs that do not perform urine testing among at least 10% of their non-urologic, non-transplant surgery procedures
- VAMCs that already have implemented interventions to reduce perioperative urine testing
- VAMCs' units performing genitourinary or transplant surgeries
- Database of patients with a diagnosis of urinary tract infection within 30 days before surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, 53705-2254, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marin L. Schweizer-Looby, PhD BS
William S. Middleton Memorial Veterans Hospital, Madison, WI
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is a hybrid type 2 effectiveness/implementation study with a dual focus on clinical effectiveness and implementation outcomes using a stepped wedge cluster randomized trial among six recruited VAMCs.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2026
First Posted
February 13, 2026
Study Start (Estimated)
December 31, 2026
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2030
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share